BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30828155)

  • 1. Absolute Monocyte Count is Superior than Absolute Lymphocyte Count at Day 28 as an Independent Prognostic Factor in Acute Myeloid Leukemia.
    Ismail MM; Abdulateef NAB
    Indian J Hematol Blood Transfus; 2019 Jan; 35(1):100-108. PubMed ID: 30828155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prognostic impact of absolute lymphocyte count, absolute monocyte count, absolute lymphocyte count/absolute monocyte count prognostic score and ratio in patients with diffuse large B cell lymphoma.
    Markovic O; Popovic L; Marisavljevic D; Jovanovic D; Filipovic B; Stanisavljevic D; Matovina-Brko G; Hajder J; Matkovic T; Živkovic R; Stanisavljevic N; Todorović M; Petrovic D; Mihaljevic B
    Eur J Intern Med; 2014 Mar; 25(3):296-302. PubMed ID: 24565533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
    De Angulo G; Yuen C; Palla SL; Anderson PM; Zweidler-McKay PA
    Cancer; 2008 Jan; 112(2):407-15. PubMed ID: 18058809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
    Behl D; Porrata LF; Markovic SN; Letendre L; Pruthi RK; Hook CC; Tefferi A; Elliot MA; Kaufmann SH; Mesa RA; Litzow MR
    Leukemia; 2006 Jan; 20(1):29-34. PubMed ID: 16281063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer.
    Eo WK; Jeong DW; Chang HJ; Won KY; Choi SI; Kim SH; Chun SW; Oh YL; Lee TH; Kim YO; Kim KH; Ji YI; Kim A; Kim HY
    World J Gastroenterol; 2015 Mar; 21(9):2668-76. PubMed ID: 25759535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant.
    Thoma MD; Huneke TJ; DeCook LJ; Johnson ND; Wiegand RA; Litzow MR; Hogan WJ; Porrata LF; Holtan SG
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):600-7. PubMed ID: 21843495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia.
    Feng J; Zhang W; Wu J; Gao S; Ye H; Sun L; Chen Y; Yu K; Xing CY
    Leuk Lymphoma; 2016 Nov; 57(11):2548-54. PubMed ID: 27074049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of absolute lymphocyte count/absolute monocyte count ratio at diagnosis in patients with multiple myeloma.
    Shin SJ; Roh J; Kim M; Jung MJ; Koh YW; Park CS; Yoon DH; Suh C; Park CJ; Chi HS; Huh J
    Korean J Pathol; 2013 Dec; 47(6):526-33. PubMed ID: 24421845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal Absolute Monocyte Count in Combination with Normal/High Absolute Lymphocyte Count at the Time of Relapse is Associated with Improved Survival in Patients with Early Relapsed Acute Myeloid Leukemia.
    Zhang Y; Dai K; Zhang Q; Huang Y; Feng Y; Bhardwaj D; Yu K; Feng J
    Cancer Invest; 2021; 39(6-7):550-558. PubMed ID: 34027748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Implication of the Absolute Lymphocyte to Absolute Monocyte Count Ratio in Patients With Classical Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine or Equivalent Regimens.
    Vassilakopoulos TP; Dimopoulou MN; Angelopoulou MK; Petevi K; Pangalis GA; Moschogiannis M; Dimou M; Boutsikas G; Kanellopoulos A; Gainaru G; Plata E; Flevari P; Koutsi K; Papageorgiou L; Telonis V; Tsaftaridis P; Sachanas S; Yiakoumis X; Tsirkinidis P; Viniou NA; Siakantaris MP; Variami E; Kyrtsonis MC; Meletis J; Panayiotidis P; Konstantopoulos K
    Oncologist; 2016 Mar; 21(3):343-53. PubMed ID: 26921291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation.
    Embaby A; Fathy A; Al-Akkad M; Baraka A; Ibrahim T; Zidan N; Refaat M; Elsheikh H
    J Egypt Natl Canc Inst; 2020 Aug; 32(1):33. PubMed ID: 32743788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial absolute lymphocyte count as a prognostic factor for outcome in acute myeloid leukemia.
    Le Jeune C; Bertoli S; Elhamri M; Vergez F; Borel C; Huguet F; Michallet M; Dumontet C; Recher C; Thomas X
    Leuk Lymphoma; 2014 Apr; 55(4):855-62. PubMed ID: 23786457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
    Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
    Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma.
    Tamura A; Inoue S; Mori T; Noguchi J; Nakamura S; Saito A; Kozaki A; Ishida T; Sadaoka K; Hasegawa D; Kosaka Y; Miyanishi M
    Front Oncol; 2020; 10():572413. PubMed ID: 33123478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.
    Rochet NM; Kottschade LA; Grotz TE; Porrata LF; Markovic SN
    Am J Clin Oncol; 2015 Jun; 38(3):252-8. PubMed ID: 23774073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphocyte Count before First Consolidation Therapy Is A Predictor of Relapse free Survival in Acute Myeloid Leukemia].
    Pang YB; Fan LX; Tian MJ; Zhao SY; Hua LM; Luo JM; DU X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):993-998. PubMed ID: 30111396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of absolute lymphocyte and monocyte counts at diagnosis of diffuse large B-cell lymphoma in the rituximab era.
    Aoki K; Tabata S; Yonetani N; Matsushita A; Ishikawa T
    Acta Haematol; 2013; 130(4):242-6. PubMed ID: 23860478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.
    Porrata LF; Ristow K; Habermann TM; Ozsan N; Dogan A; Macon W; Colgan JP; Witzig TE; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski GS; Thompson C; Markovic SN
    Leuk Lymphoma; 2012 Nov; 53(11):2159-65. PubMed ID: 22551474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
    Jelicic J; Balint MT; Jovanovic MP; Boricic N; Micev M; Stojsic J; Antic D; Andjelic B; Bila J; Balint B; Pavlovic S; Mihaljevic B
    Pathol Oncol Res; 2016 Jul; 22(3):567-77. PubMed ID: 26750138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma.
    Porrata LF; Ristow KM; Habermann TM; Macon WR; Witzig TE; Colgan JP; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Nowakowski G; Thompson CA; Markovic SN
    Blood Cancer J; 2013 Apr; 3(4):e110. PubMed ID: 23599022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.